For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called "antigens"). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler - scientists at the Roche-funded Basel Institute for Immunology - who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Scope of the Report:
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
There is a gap between China antibody manufacturers and Europe/America. In China, about 26% of consumption antibody import from foreign manufactures, such as Hytest, Roche, Thermo Fisher. There are also some local producers, such as Fapon, Genscript, Kitgen, Leadman, MACCURA, Wondfo, etc. Fapon is the leading player in China.
In classification, antibody can be divided into polyclonal antibody and monoclonal antibody. Monoclonal antibody hold the mostly share the China share about 91.12%
In application, antibody downstream is wide and recently antibody has impacted by the hospital, medical research institutions, etc. Hospital holds about 91.21% of whole China antibody consumption in 2016.
The manufacture region is concentrated in Central China, East China and Southwest China, of which East China is the largest region with the share 33.20% in 2016. The sales shares of Southwest China and Central China were 15.12% and 14.56%.
The worldwide market for Antibody is expected to grow at a CAGR of roughly 5.4% over the next five years, will reach 9530 million US$ in 2024, from 7330 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Antibody in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Roche
- Johnson & Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- IgM
- IgG
- IgA
- Other
Market Segment by Applications, can be divided into
- Therapeutic
- Research
- Diagnostic
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody, with price, sales, revenue and global market share of Antibody in 2017 and 2018.
Chapter 3, the Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antibody market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.